Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Indian Pediatr ; 58(12): 1136-1139, 2021 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-34939581

RESUMO

OBJECTIVE: This study was done to analyze the profile of confirmed pediatric TB patients seen in an intensive care setting. METHODS: Data of all children admitted in our PICU with bacteriologically proven tuberculosis (smear, culture, poly-merase chain reaction, genotypic testing or Pyrosequencing) between January, 2007 and December, 2019 were retrieved. Drug resistance was classified as per World Health Organization definitions. RESULTS: 59 children (28 boys) met the inclusion criteria (median (IQR) age 8 (4,13) years). About a third (22/59) had past history of treatment with antituberculosis drugs. The indications for admission to PICU were monitoring and management of neurological status in 31 children, post procedure monitoring in 20 children and respiratory failure in 8 children. Severe ARDS was seen in 2 children. Out of 37 children with neuro-tuberculosis, 19 children had TB in additional sites, and 9 children died. Sample positivity rate for CSF culture was 66%. Drug sensitivity testing (DST) of positive culture was done in 35 cases and showed multidrug resistance in 4 children, pre-XDR (extreme drug resistance) in 10 and XDR in 5 children. CONCLUSION: Neurotuberculosis was the commonest reason for admission to PICU. Concerted efforts should be made to obtain samples for culture and drug sensitivity testing in critically ill children with tuberculosis.


Assuntos
Mycobacterium tuberculosis , Insuficiência Respiratória , Tuberculose Resistente a Múltiplos Medicamentos , Tuberculose , Antituberculosos/uso terapêutico , Criança , Humanos , Unidades de Terapia Intensiva Pediátrica , Masculino , Tuberculose/tratamento farmacológico , Tuberculose Resistente a Múltiplos Medicamentos/tratamento farmacológico , Organização Mundial da Saúde
3.
Indian Pediatr ; 58(6): 568-571, 2021 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-33612486

RESUMO

OBJECTIVE: To evaluate if Healthcare workers (HCWs) at the frontline of COVID-19 response in a pediatric hospital are at an increased risk of acquiring SARS-CoV-2. METHODS: The Hospital Infection Control Committee (HICC) and virology testing records were combined to identify SARS-CoV-2 positive HCWs and study the transmission dynamics of COVID-19 over 6 months. RESULTS: COVID-19 cases in our HCWs cohort rose and declined parallel to community cases. Forty two out of 534 HCWs (8%) were SARS-CoV-2 positive with no fatalities. No clinical staff in the special COVID ward or ICU was positive. Significant proportion of non-clinical staff (30%) were SARS-CoV-2 positive. About 70% of SARS-CoV-2 positive staff had likely community acquisition, with a significant proportion having travelled by public transport or having a contact history with a positive case in the community. Twenty four percent of positive staff were asymptomatic and detected positive on re-joining test. CONCLUSIONS: Sustained transmission of SARS-CoV-2 did not occur in our cohort beyond community transmission. Appropriate PPE use, strict and constantly improving infection control measures and testing of both clinical and non-clinical staff were essential methods for restricting transmission amongst HCWs.


Assuntos
COVID-19/diagnóstico , COVID-19/transmissão , Transmissão de Doença Infecciosa/estatística & dados numéricos , Pessoal de Saúde/estatística & dados numéricos , Adulto , COVID-19/epidemiologia , Criança , Transmissão de Doença Infecciosa/prevenção & controle , Feminino , Hospitais Pediátricos , Humanos , Controle de Infecções , Masculino , Pessoa de Meia-Idade , Equipamento de Proteção Individual , SARS-CoV-2
4.
Indian J Crit Care Med ; 24(8): 628-629, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33024366

RESUMO

Scoring systems in intensive care units allow assessment of the severity of disease and predicting mortality. They also help in allocation of resources and benchmarking performance when compared to other units and hence to development of skills within a unit. Their use needs to go beyond just mortality prediction and unit statistics. The data collected are useful for resource allocation, unit audits, comparison with local units as well as for quality improvement programs and education. HOW TO CITE THIS ARTICLE: Udani S. A Good Workman Never Blames His Tools: Appropriate Use of Severity of Illness Scoring Systems Determines Their Utility! Indian J Crit Care Med 2020;24(8):628-629.

5.
Indian J Crit Care Med ; 24(6): 380, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32863625

RESUMO

The commentary is to highlight not the profile of scrub typhus but the correlation of serology with immunofluorescence. How to cite this article: Udani S. Pediatric Scrub Typhus: A Commentary. Indian J Crit Care Med 2020;24(6):380.

6.
Indian Pediatr ; 57(11): 1015-1019, 2020 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-32788432

RESUMO

OBJECTIVE: We describe the presentation, treatment and outcome of children with multisystem inflammatory syndrome with COVID-19 (MIS-C) in Mumbai metropolitan area in India. METHOD: This is an observational study conducted at four tertiary hospitals in Mumbai. Parameters including demographics, symptomatology, laboratory markers, medications and outcome were obtained from patient hospital records and analyzed in patients treated for MIS-C (as per WHO criteria) from 1 May, 2020 to 15 July, 2020. RESULTS: 23 patients (11 males) with median (range) age of 7.2 (0.8-14) years were included. COVID-19 RT-PCR or antibody was positive in 39.1% and 30.4%, respectively; 34.8% had a positive contact. 65% patients presented in shock; these children had a higher age (P=0.05), and significantly higher incidence of myocarditis with elevated troponin, NT pro BNP and left ventri-cular dysfunction, along with significant neutrophilia and lympho-penia, as compared to those without shock. Coronary artery dilation was seen in 26% patients overall. Steroids were used most commonly for treatment (96%), usually along with intra-venous immunoglobulin (IVIg) (65%). Outcome was good with only one death. CONCLUSION: Initial data on MIS-C from India is presented. Further studies and longer surveillance of patients with MIS-C are required to improve our diagnostic, treatment and surveillance criteria.


Assuntos
COVID-19/diagnóstico , Síndrome de Resposta Inflamatória Sistêmica/diagnóstico , Adolescente , Biomarcadores/sangue , COVID-19/epidemiologia , COVID-19/terapia , Criança , Pré-Escolar , Feminino , Glucocorticoides/uso terapêutico , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Índia/epidemiologia , Lactente , Linfopenia/etiologia , Masculino , Miocardite/etiologia , Peptídeo Natriurético Encefálico/sangue , Neutrófilos/metabolismo , Fragmentos de Peptídeos/sangue , Choque/etiologia , Síndrome de Resposta Inflamatória Sistêmica/epidemiologia , Síndrome de Resposta Inflamatória Sistêmica/terapia , Troponina/sangue , Disfunção Ventricular Esquerda/etiologia
7.
Pediatr Crit Care Med ; 21(5): e228-e235, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32106187

RESUMO

OBJECTIVES: To determine current management of critically ill children and gather views regarding high flow nasal cannula therapy and to evaluate research priorities for a large prospective randomized controlled trial of noninvasive respiratory support in children. DESIGN: Multinational cross-sectional questionnaire survey conducted in 2018. SETTING: The sample included pediatric intensive care physicians in North and South America, Asia, Europe, and Australia/New Zealand. MEASUREMENT: Questions consisted of: 1) characteristics of intensivists and hospital, 2) practice of high flow nasal cannula, 3) supportive treatment, and 4) research of high flow nasal cannula. INTERVENTIONS: None. MAIN RESULTS: We collected data from 1,031 respondents; 919 (North America, 215; Australia/New Zealand, 34; Asia, 203; South America, 186; Europe, 281) were analyzed. Sixty-nine percent of the respondents used high flow nasal cannula in non-PICU settings in their institutions. For a case of bronchiolitis/pneumonia infant, 2 L/kg/min of initial flow rate was the most commonly used. For a scenario of pneumonia with 30 kg weight, more than 60% of the respondents initiated flow based on patient body weight; while, 18% applied a fixed flow rate. Noninvasive ventilation was considered as a next step in more than 85% of respondents when the patient is failing with high flow nasal cannula. Significant practice variations were observed in clinical practice markers used, flow weaning strategy, and supportive practices. Views comparing high flow nasal cannula to continuous positive airway pressure also noticeably varied across the respondents. CONCLUSIONS: Significant practice variations including views of high flow nasal cannula compared to continuous positive airway pressure was found among pediatric intensive care physicians. To expedite establishment and standardization of high flow nasal cannula practice, research aimed at understanding the heterogeneity found in this study should be undertaken.


Assuntos
Cânula , Estado Terminal , Criança , Pressão Positiva Contínua nas Vias Aéreas , Estado Terminal/terapia , Estudos Transversais , Europa (Continente) , Humanos , Lactente , América do Norte , Oxigenoterapia , Estudos Prospectivos , América do Sul
8.
Pediatr Infect Dis J ; 38(9): e228-e230, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31033906

RESUMO

Isolated cases of septicemia associated with probiotics have been reported. We describe Bacillus clausii septicemia in a 4-month-old male infant with congenital heart disease following treatment for diarrhea with a probiotic containing B. clausii spores. The septicemia proved refractory to treatment with antibiotics active against the pathogen and progressed to multidrug-resistant sepsis with multiorgan failure.


Assuntos
Bacillus clausii/patogenicidade , Diarreia/terapia , Probióticos/efeitos adversos , Sepse/diagnóstico , Sepse/etiologia , Antibacterianos/uso terapêutico , Bacillus clausii/efeitos dos fármacos , Farmacorresistência Bacteriana Múltipla , Evolução Fatal , Humanos , Lactente , Masculino , Insuficiência de Múltiplos Órgãos/microbiologia , Sepse/tratamento farmacológico , Sepse/microbiologia
9.
Indian J Pediatr ; 82(3): 272-6, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25307455

RESUMO

The neurologically injured child, whether from trauma or other causes, is a common admission into any Pediatric critical care unit. Whatever the cause, the risk for death and life long disability remains very high. Unlike the adult population, neurological diseases in children are diverse and arise from a variety of factors that vary greatly in age and presentation. Nervous system dysfunction is often a complication of critical illness and interventions. While neurointensive care units may be ideal for the at-risk child, in mixed units, 40 % of admissions may be neurological or have neurological complications. Improved quality of care and the application of protocols and bundles, appear to have contributed significantly to improved outcomes. Since we are constantly facing an uphill task of dealing with deterioration while trying to preserve function, detection of early shifts of any nature would be deemed helpful. The intensivist must focus not only on saving life but also on preventing disability with full awareness that responsibility does not end with discharge from the pediatric intensive care unit (PICU). Outcome audits should include not only deaths and discharge from PICU but also one year mortality and even degree of disability at the end of one year from discharge.


Assuntos
Circulação Cerebrovascular , Doenças do Sistema Nervoso , Monitorização Neurofisiológica/métodos , Criança , Cuidados Críticos/métodos , Cuidados Críticos/normas , Estado Terminal , Humanos , Doenças do Sistema Nervoso/diagnóstico , Doenças do Sistema Nervoso/etiologia , Doenças do Sistema Nervoso/fisiopatologia , Doenças do Sistema Nervoso/prevenção & controle , Neuroproteção
10.
Indian J Crit Care Med ; 14(1): 41-52, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20606908

RESUMO

JUSTIFICATION: Pediatric sepsis is a commonly encountered global issue. Existing guidelines for sepsis seem to be applicable to the developed countries, and only few articles are published regarding application of these guidelines in the developing countries, especially in resource-limited countries such as India and Africa. PROCESS: An expert representative panel drawn from all over India, under aegis of Intensive Care Chapter of Indian Academy of Pediatrics (IAP) met to discuss and draw guidelines for clinical practice and feasibility of delivery of care in the early hours in pediatric patient with sepsis, keeping in view unique patient population and limited availability of equipment and resources. Discussion included issues such as sepsis definitions, rapid cardiopulmonary assessment, feasibility of early aggressive fluid therapy, inotropic support, corticosteriod therapy, early endotracheal intubation and use of positive end expiratory pressure/mechanical ventilation, initial empirical antibiotic therapy, glycemic control, and role of immunoglobulin, blood, and blood products. OBJECTIVE: To achieve a reasonable evidence-based consensus on the basis of published literature and expert opinion to formulating clinical practice guidelines applicable to resource-limited countries such as India. RECOMMENDATIONS: Pediatric sepsis guidelines are presented in text and flow chart format keeping resource limitations in mind for countries such as India and Africa. Levels of evidence are indicated wherever applicable. It is anticipated that once the guidelines are used and outcomes data evaluated, further modifications will be necessary. It is planned to periodically review and revise these guidelines every 3-5 years as new body of evidence accumulates.

11.
Mol Diagn ; 9(2): 59-66, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16137181

RESUMO

BACKGROUND: Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CFTR gene. The most severe, DeltaF508, mutation accounts for nearly 70% of CF cases worldwide. Besides DeltaF508, there are other point mutations, namely G542X, G551D, R553X, N1303K, and 621+1(G-->T), which are common among Caucasians. Additionally, a polyT polymorphism in intron 8 is also involved in the pathogenesis of CF. However, neither the prevalence nor the types of mutations causing CF in India are known. In this study, we aimed at estimating the frequency of the above common mutations and polymorphism in clinically suspected CF cases. We also carried out partial analysis of the CFTR gene, limited to exons 10 and 11, to identify other variations in these exons. METHODS: The multiplex amplification refractory mutation system (ARMS) test was applied for rapid simultaneous analysis of six most common CF mutations, in 100 normal and 39 elevated sweat chloride cases. The scanning of exons 10 and 11 was carried out by single-stranded conformation polymorphism/heteroduplex (SSCP/HD) analysis, followed by DNA sequencing in 50 normal and 37 elevated sweat chloride cases. A single ARMS-polymerase chain reaction assay was used to distinguish the 5T, 7T, and 9T alleles in 100 normal and 33 elevated sweat chloride cases. RESULTS: The multiplex ARMS analysis identified the DeltaF508 mutation at an allele frequency of 24% in Indian CF cases. However, the other predominant CF mutations were found to be absent. The 7T polyT variant was observed to be the most common allele, followed by the 9T, and 5T, which was the lowest. The DeltaF508 mutation was observed in all instances with the 9T variant. The SSCP/HD and DNA sequencing additionally revealed a known polymorphism (M470V, exon 10) and a known mutation [1525-1(G-->A), intron 9]. The 1525-1(G-->A) mutation, observed in a single 4-year-old male, is predicted to code for a class II defective CFTR protein. CONCLUSION: The findings of this study suggest a difference in relative frequencies and spectrum of CFTR mutations in Indian CF cases. A larger screening study of the entire CFTR gene in clinically well defined CF cases is required to delineate common mutations in the CFTR gene and enable molecular diagnosis of CF in India.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/diagnóstico , Fibrose Cística/genética , Polimorfismo Conformacional de Fita Simples , Substituição de Aminoácidos , Axônios , Amplificação de Genes , Frequência do Gene , Variação Genética , Humanos , Índia , Mutação Puntual , Deleção de Sequência
12.
Indian Pediatr ; 40(9): 870-3, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-14530547

RESUMO

Infantile hydrocephalus due to unrecognized neonatal-onset meningitis/ventriculitis, was studied retrospectively using 1991-1998 chart review. Seventy two patients with hydrocephalus were reviewed. Thirteen infants had hydrocephalus associated with active meningitis/ventriculitis which had remained unrecognized. Active meningitis/ventriculitis was confirmed by the finding of an abnormal lumbar and ventricular CSF with or without positive culture. All had perinatal risk factors and 10/13 had been given antibiotics in the postnatal period. 6/13 infants appeared to be well. The most common presentation was increasing head size. All lumbar and ventricular CSFs were abnormal and 10/13 had positive cultures as well. Imaging revealed hydrocephalus in all. The infants were treated with antibiotics for a mean of 32.8 days before VP shunting. 7/11 were severely disabled. Unrecognized active meningitis/ventriculitis is an important cause of infantile hydrocephalus.


Assuntos
Ventrículos Cerebrais/patologia , Encefalite/diagnóstico , Hidrocefalia/etiologia , Meningite/diagnóstico , Feminino , Humanos , Lactente , Masculino , Estudos Retrospectivos , Tuberculose Meníngea/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA